Biostage appoints David Green as interim CEO; he invests $250,000 in private placement

Harvard Apparatus Regenerative Technology, Inc.

David Green appointed Interim CEO and Chairman; Jason Chen becomes Vice Chairman.
Green invests $250,000 for 72,464 shares and warrant for 36,232 shares at $3.45 (50% premium to Nov 26 close).
Green's salary set at Massachusetts minimum wage ($35,568) plus option grant of 374,094 shares (2/3 vest on milestones).
Green previously served as CEO and Chairman until 2015; returns to lead Biostage's esophageal implant development.

item 1.01 item 3.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

David Green

Chairman of the Board

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2021-11-26
Filed: November 30, 2021, 6:59 PM ET

Mr. Green also joined the Board as a Class II director and was appointed Chairman of the Board.

Appointed (interim)

David Green

Interim Chief Executive Officer

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2021-11-26
Filed: November 30, 2021, 6:59 PM ET

Effective as of November 26, 2021, the Company appointed Mr. Green as Interim Chief Executive Officer.

Role change

Jason Chen

Vice Chairman of the Board

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2021-11-26
Filed: November 30, 2021, 6:59 PM ET

the Company’s existing Chairman, Jason Chen, was appointed Vice Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Green was appointed as Chairman of the Board at Harvard Apparatus Regenerative Technology, Inc..

Action: appointed
Role: Chairman of the Board

Exact text from the filing

Mr. Green also joined the Board as a Class II director and was appointed Chairman of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Green was appointed as Interim Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

Effective as of November 26, 2021, the Company appointed Mr. Green as Interim Chief Executive Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason Chen was appointed as Vice Chairman of the Board at Harvard Apparatus Regenerative Technology, Inc..

Action: appointed
Role: Vice Chairman of the Board

Exact text from the filing

the Company’s existing Chairman, Jason Chen, was appointed Vice Chairman of the Board.

View on SEC.gov

Harvard Apparatus Regenerative Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-21-144727

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.